Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) Results build on data previously presented ...

Pulmonary arterial hypertension, a disease that leads to worsening lung and heart problems that eventually become life-threatening, is treated with drugs that alleviate symptoms. FDA approval of a new ...

Although the precise mechanism isn’t yet known, factors like sex chromosomes and hormones, particularly the protective ...

A 40-year-old woman who was once accustomed to frequent travel suddenly found herself struggling to breathe after just a few ...

Please provide your email address to receive an email when new articles are posted on . A pulmonary artery sensor for patients with heart failure beat performance goals related to clinical outcomes.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...